Novo Settles Drug Marketing Claims For $26.7M
By Martin Bricketto ( June 10, 2011, 3:36 PM EDT) -- Novo Nordisk Inc. announced Friday that it would pay $26.7 million to resolve federal investigations and False Claims Act lawsuits in New York and Maryland brought by former employees and a physician over the marketing of its drugs for bleeding disorders and diabetes....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.